http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101643953-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1455 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-00 |
| filingDate | 2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101643953-B1 |
| titleOfInvention | Method and apparatus for detecting diseases associated with the eye |
| abstract | The present invention relates to a disease that can be detected and monitored by detecting metabolic dysfunction in a patient's eye. In one embodiment of the device, the excitation light is generated by an excitation light source to induce autofluorescence in the eye tissue (e.g., retina tissue), wherein the excitation light excites the autofluorescence (FA) of the yellow protein The excitation of the autofluorescence of the non-yellow protein is minimized. The induced ocular tissue captures at least a single image indicative of fluorescence. At least a single image is augmented to increase the signal intensity of autologous fluorescence. At least a single image is analyzed to determine whether the patient has at least one of the following diseases: eye damage, eye damage, progression of the disease, efficacy of the treatment, tailored treatment to the subject, and the like. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230085805-A |
| priorityDate | 2007-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.